220 related articles for article (PubMed ID: 33228790)
41. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
42. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
[TBL] [Abstract][Full Text] [Related]
43. [Verification of the diagnosis of supratentorial ependymomas by real-time PCR].
Galstyan SA; Telysheva EN; Lavrinovich AO; Shaikhaev EG; Snigireva GP; Petrova EI; Gorelyshev SK; Zheludkova OG; Kushel YV; Kumirova EV; Ryzhova MV
Arkh Patol; 2023; 85(3):5-11. PubMed ID: 37272434
[TBL] [Abstract][Full Text] [Related]
44. Magnetic Resonance Imaging Features of Zinc Finger Translocation Associated-RELA Fusion Ependymoma Compared to Its Wild-Type Counterpart.
Shao H; Chen N; Su X; Zheng L; Yang X; Wan X; Zhang S; Tan Q; Li S; Gong Q; Yue Q
World Neurosurg; 2023 Jul; 175():e1283-e1291. PubMed ID: 37149089
[TBL] [Abstract][Full Text] [Related]
45. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
[TBL] [Abstract][Full Text] [Related]
46. RELA Fusion-Positive Ependymoma in a Child with Down Syndrome: A Case Report.
Chan JL; Kashanian A; Bannykh SI; Majlessipour F; Breunig JJ; Danielpour M
Pediatr Neurosurg; 2021; 56(2):146-151. PubMed ID: 33690230
[TBL] [Abstract][Full Text] [Related]
47. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.
de Almeida Magalhães T; Alencastro Veiga Cruzeiro G; Ribeiro de Sousa G; Englinger B; Fernando Peinado Nagano L; Ancliffe M; Rodrigues da Silva K; Jiang L; Gojo J; Cherry Liu Y; Carline B; Kuchibhotla M; Pinto Saggioro F; Kazue Nagahashi Marie S; Mieko Oba-Shinjo S; Andres Yunes J; Gomes de Paula Queiroz R; Alberto Scrideli C; Endersby R; Filbin MG; Silva Borges K; Salic A; Gonzaga Tone L; Valera ET
Neuro Oncol; 2023 Jan; 25(1):185-198. PubMed ID: 35640920
[TBL] [Abstract][Full Text] [Related]
48. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
Jones RA; Moorehead RA
Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
[TBL] [Abstract][Full Text] [Related]
49. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
[TBL] [Abstract][Full Text] [Related]
50.
Kupp R; Ruff L; Terranova S; Nathan E; Ballereau S; Stark R; Sekhar Reddy Chilamakuri C; Hoffmann N; Wickham-Rahrmann K; Widdess M; Arabzade A; Zhao Y; Varadharajan S; Zheng T; Murugesan M; Pfister SM; Kawauchi D; Pajtler KW; Deneen B; Mack SC; Masih KE; Gryder BE; Khan J; Gilbertson RJ
Cancer Discov; 2021 Sep; 11(9):2216-2229. PubMed ID: 33741711
[No Abstract] [Full Text] [Related]
51. Aggressive Supratentorial Ependymoma, RELA Fusion-Positive with Extracranial Metastasis: A Case Report.
Kim SI; Lee Y; Kim SK; Kang HJ; Park SH
J Pathol Transl Med; 2017 Nov; 51(6):588-593. PubMed ID: 29161788
[TBL] [Abstract][Full Text] [Related]
52. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M
Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956
[TBL] [Abstract][Full Text] [Related]
53. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
[TBL] [Abstract][Full Text] [Related]
54. Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.
Pietsch T; Wohlers I; Goschzik T; Dreschmann V; Denkhaus D; Dörner E; Rahmann S; Klein-Hitpass L
Acta Neuropathol; 2014 Apr; 127(4):609-11. PubMed ID: 24562983
[No Abstract] [Full Text] [Related]
55. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
[TBL] [Abstract][Full Text] [Related]
56. Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.
Oldrini B; Curiel-García Á; Marques C; Matia V; Uluçkan Ö; Graña-Castro O; Torres-Ruiz R; Rodriguez-Perales S; Huse JT; Squatrito M
Nat Commun; 2018 Apr; 9(1):1466. PubMed ID: 29654229
[TBL] [Abstract][Full Text] [Related]
57. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
[TBL] [Abstract][Full Text] [Related]
58.
Tabasaran J; Schuhmann M; Ebinger M; Honegger J; Renovanz M; Schittenhelm J
J Clin Pathol; 2022 Nov; 75(11):759-765. PubMed ID: 34183436
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
Nambirajan A; Malgulwar PB; Sharma A; Boorgula MT; Doddamani R; Singh M; Suri V; Sarkar C; Sharma MC
Brain Tumor Pathol; 2019 Oct; 36(4):152-161. PubMed ID: 31388782
[TBL] [Abstract][Full Text] [Related]
60. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
